-1753360911472.webp&w=3840&q=75)
2025 NOSCM | Management of Unresectable Stage III NSCLC
Overview
Dr. Corey Langer emphasized the importance of multidisciplinary management for stage III NSCLC, noting the PACIFIC and ECOG 5181 trials.
Target Audience
Physicians
Nurses
Pharmacists
Physician Associates
This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.
Faculty
Corey Langer, MD
Date of Release
July 24th, 2025
-1755990775594.webp&w=3840&q=75)
-1755990700517.webp&w=3840&q=75)